The Biden administration could use the Defense Production Act to loosen up access to cell lines and manufacturing expertise for coronavirus vaccines if the World Trade Organization follows the U.S. government’s advice to waive patent protections for the vaccines , according to advocates for breaking coronavirus vaccine patents, including Knowledge Ecology International and Public Citizen. Drug executives say the WTO waiver is useless because no one other than those who invented the vaccines know how to make them, especially vaccines...